Formulary Drug Review: Belumosudil.

Journal

Hospital pharmacy

ISSN: 0018-5787

Titre abrégé: Hosp Pharm

Pays: United States

ID NLM: 0043175

Informations de publication

Date de publication:
Aug 2022

Historique:

entrez: 28 7 2022

pubmed: 29 7 2022

medline: 29 7 2022

Statut: ppublish

Résumé

Each month, subscribers to

Identifiants

DOI: 10.1177/00185787211061381 PMID: 35898245 PMC: PMC9310299

pubmed: 35898245

doi: 10.1177/00185787211061381

pii: 10.1177_00185787211061381

pmc: PMC9310299

doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

435-441

Informations de copyright

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Clin Invest. 2017 Jun 30;127(7):2452-2463

pubmed: 28665299

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16814-9

pubmed: 25385601

J Clin Oncol. 2021 Jun 10;39(17):1888-1898

pubmed: 33877856

J Immunol. 2017 May 15;198(10):3809-3814

pubmed: 28389592

Pharmacotherapy. 2020 Aug;40(8):756-772

pubmed: 32441379

Ann Rheum Dis. 2016 Apr;76(4):740-747

pubmed: 28283529

Adipocyte. 2019 Dec;8(1):114-124

pubmed: 30860936

Blood. 2016 Apr 28;127(17):2144-54

pubmed: 26983850

Eur J Immunol. 2018 Oct;48(10):1679-1686

pubmed: 30098001

Blood. 2021 Dec 2;138(22):2278-2289

pubmed: 34265047